NDC 27293-019-14 - Budpak Oral Maximum Strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 27293-019
- Requested NDC
- 27293-019-14
- Package NDCs from labels
- 27293-019-14, 27293-019-01
- Manufacturer
- Budpak Inc. | Anicare Pharmaceuticals Pvt. Ltd
- Effective date
- 2013-06-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Budpak Oral Maximum Strength - Budpak Inc. | Anicare Pharmaceuticals Pvt. Ltd | Budpak Inc. | Anicare Pharmaceuticals Pvt. Ltd | 2013-06-08 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 27293-019-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-6a3c-f424-e053-dadaa90a57ce | f1908054-8527-421a-a023-0476a71c9691 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 27293-019-01 | Budpak Oral Maximum Strength | 1 in 1 BOX | GEL | 1 | 1 | |
| 27293-019-14 | Budpak Oral Maximum Strength | 14 g in 1 TUBE | GEL | 14 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| BENZOCAINE | ACTIVE INGREDIENT | U3RSY48JW5 | BUDPAK ORAL MAXIMUM STRENGTH (BENZOCAINE) GEL [BUDPAK INC.] | 1 | |
| BENZOCAINE | ACTIVE MOIETY | U3RSY48JW5 | BUDPAK ORAL MAXIMUM STRENGTH (BENZOCAINE) GEL [BUDPAK INC.] | 1 | |
| GLYCYRRHIZIN, AMMONIATED | INACTIVE INGREDIENT | 3VRD35U26C | BUDPAK ORAL MAXIMUM STRENGTH (BENZOCAINE) GEL [BUDPAK INC.] | 1 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | BUDPAK ORAL MAXIMUM STRENGTH (BENZOCAINE) GEL [BUDPAK INC.] | 1 | |
| SACCHARIN SODIUM | INACTIVE INGREDIENT | SB8ZUX40TY | BUDPAK ORAL MAXIMUM STRENGTH (BENZOCAINE) GEL [BUDPAK INC.] | 1 | |
| SORBIC ACID | INACTIVE INGREDIENT | X045WJ989B | BUDPAK ORAL MAXIMUM STRENGTH (BENZOCAINE) GEL [BUDPAK INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Avant | BENZOCAINE | Dharma Research, Inc. | e10c45e6-d37f-4650-b3e5-07719cc0ea49 | 2023-10-11 | Warnings | U3RSY48JW5 |
| Avant | BENZOCAINE | Dharma Research, Inc. | 886d949b-8db1-499c-a277-174f8bc29f34 | 2023-10-11 | Warnings | U3RSY48JW5 |
| Avant | BENZOCAINE | Dharma Research, Inc. | fc8194af-2e77-4ad1-ae75-461dce3ed604 | 2023-10-11 | Warnings | U3RSY48JW5 |
| Avant | BENZOCAINE | Dharma Research, Inc. | baf7d184-07ed-4491-a1fc-9a377b4b0110 | 2023-10-11 | Warnings | U3RSY48JW5 |
| Avant | BENZOCAINE | Dharma Research, Inc. | 033034af-c86c-4dbf-90eb-009c117024c6 | 2023-10-11 | Warnings | U3RSY48JW5 |
| Avant | BENZOCAINE | Dharma Research, Inc. | 658ada18-2334-4b4e-b08e-702fa127aa14 | 2023-10-11 | Warnings | U3RSY48JW5 |
| Avant | BENZOCAINE | Dharma Research, Inc. | cad932e5-8d7f-4f20-b1c2-febd328152f0 | 2023-10-11 | Warnings | U3RSY48JW5 |
| Iolite | BENZOCAINE | Dharma Research, Inc. | 2c9519ab-320d-49da-9deb-97a6168fb088 | 2023-10-10 | Warnings | U3RSY48JW5 |
| Ioline | BENZOCAINE | Dharma Research, Inc. | b862c974-c024-42c3-986e-b65069437c7b | 2023-10-10 | Warnings | U3RSY48JW5 |
| Iolite | BENZOCAINE | Dharma Research, Inc. | 651ea978-081d-4c59-b177-6049a69d9415 | 2023-10-10 | Warnings | U3RSY48JW5 |
| Iolite | BENZOCAINE | Dharma Research, Inc. | db763237-2910-45b9-be72-da092edc951b | 2023-10-10 | Warnings | U3RSY48JW5 |
| Iolite | BENZOCAINE | Dharma Research, Inc. | 34316f93-10b4-41cc-8654-625283f0044c | 2023-10-10 | Warnings | U3RSY48JW5 |
| Iolite | BENZOCAINE | Dharma Research, Inc. | 142a8824-657e-492a-8e5a-b15eb73383c9 | 2023-10-10 | Warnings | U3RSY48JW5 |
| Iolite | BENZOCAINE | Dharma Research, Inc. | 414cbec9-94e2-4bca-908b-1e79f8db0b27 | 2023-10-10 | Warnings | U3RSY48JW5 |
| Iolite | BENZOCAINE | Dharma Research, Inc. | e4b2d22b-00b3-45a6-9b7d-8ee719587059 | 2023-10-09 | Warnings | U3RSY48JW5 |
| Iolite | BENZOCAINE | Dharma Research, Inc. | a0e284f6-292f-4231-8596-f7cee4e0a12f | 2023-10-09 | Warnings | U3RSY48JW5 |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | X045WJ989B |
| Anubis Barcelona | PROPANEDIOL, GLYCERIN, MAGNESIUM ASCORBYL PHOSPHATE | ANUBIS COSMETICS SL | eb53cba1-0509-43bc-e053-2995a90a5e09 | 2023-09-01 | Warnings | X045WJ989B |
| HurriCaine Topical Anesthetic | BENZOCAINE | Beutlich Pharmaceuticals, LLC | fe92637a-c88a-f9dd-e053-6294a90a7fa3 | 2023-07-01 | Warnings | 238910 U3RSY48JW5 |
| HurriCaine Topical Anesthetic | BENZOCAINE | Beutlich Pharmaceuticals, LLC | c979e958-2042-471a-bf03-e84e68620106 | 2023-06-20 | Warnings | 238910 U3RSY48JW5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.